129397-33-7

Basic information

• Product Name: Benzenamine, N-(2-cyclohexylethylidene)-4-methoxy-
• CAS NO: 129397-33-7
• Molecular Formula: C15H21NO
• Molecular Weight: 231.338
• Mol File: 129397-33-7.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: Benzenamine, N-(2-cyclohexylethylidene)-4-methoxy-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenamine, N-(2-cyclohexylethylidene)-4-methoxy-(129397-33-7)
• EPA Substance Registry System: Benzenamine, N-(2-cyclohexylethylidene)-4-methoxy-(129397-33-7)

Safety Data

• Hazardous Substances Data: 129397-33-7(Hazardous Substances Data)

Upstream product

• 5452-75-5 ethyl 2-cyclohexylacetate 
• 104-94-9 4-methoxy-aniline 
• 5664-21-1 cyclohexylacetaldehyde 
• 3289-28-9 ethyl cyclohexanecarboxylate 
• 2043-61-0 cyclohexanecarbaldehyde 

Downstream Products

• 144465-90-7 (3S,4R)-4-Cyclohexylmethyl-3-triisopropylsilanyloxy-azetidin-2-one 
• 121506-22-7 (2R,3S)-nor-C-statine hydrochloride 
• 140409-01-4 (2S,3R)-3-Amino-2-hydroxy-4-phenylbutyric acid hydrochloride 
• 144465-90-7 (3R,4S)-3-Triisopropylsilyloxy-4-(cyclohexylmethyl)-2-azetidinone 
• 6642-37-1 N-(4-methoxyphenyl)isobutyramide 
• 144465-85-0 1-(4-Methoxyphenyl)-3-triisopropylsilyloxy-4-(2-cyclohexylmethyl)-2-azetidinone 
• 144465-85-0 1-(4-Methoxyphenyl)-3-triisopropylsilyloxy-4-(2-cyclohexylmethyl)-2-azetidinone 
• 144465-85-0 (3R,4S)-4-(Cyclohexylmethyl)-1-(4-methoxyphenyl)-3-triisopropylsilyloxy-2-azetidinone 
• 129397-37-1 (3R*,4S*)-1-(p-anisyl)-3-benzyloxy-4-cyclohexylmethyl-2-azetidinone 

Relevant articles and documents

Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment

The present invention is directed to novel taxanes useful as chemotherapeutic agents or their precursors. Processes for preparing the novel taxanes include coupling reactions, in the presence of a base, of baccatin of formula (III) or (IV) STR1 with β-lac

Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment

The present invention is directed to novel taxanes useful as chemotherapeutic agents or their precursors. Processes for preparing the novel taxanes include coupling reactions, in the presence of a base, of baccatin of formula (III) or (IV) STR1 with β-lac

A Stereoselective Synthesis of the (2R,3S)- and (2S,3R)-3-Amino-2-hydroxybutyric Acid Derivatives, the Key Components of a Renin Inhibitor and Bestatin

The title synthesis was achieved by featuring the -cycloaddition reaction of benzyloxyketene with a chiral imine derived from methyl (R)- or (S)-mandelate, alcoholysis of the formed 3,4-cis disubstituted β-lactam under acidic conditions, and reductiv